DrugPatentWatch Database Preview
FUROSEMIDE Drug Profile
» See Plans and Pricing
When do Furosemide patents expire, and what generic alternatives are available?
Furosemide is a drug marketed by Abraxis Pharm, Accord Hlthcare, Am Regent, Amneal Pharms Co, Astrazeneca, Aurobindo Pharma Ltd, Baxter Hlthcare Corp, Emcure Pharms Ltd, Fresenius Kabi Usa, Hospira, Igi Labs Inc, Intl Medication, Marsam Pharms Llc, Smith And Nephew, Warner Chilcott, Watson Labs, West-ward Pharms Int, Wockhardt, Wyeth Ayerst, Hikma, Wockhardt Bio Ag, Ani Pharms Inc, Avet, Dava Pharms Inc, Ipca Labs Ltd, Kalapharm, Leading Pharma Llc, Mylan, Prinston Inc, Sandoz, Sun Pharm Inds Inc, Sun Pharm Industries, Superpharm, and Watson Labs Teva. and is included in fifty-eight NDAs.
The generic ingredient in FUROSEMIDE is furosemide. There are twenty-two drug master file entries for this compound. Forty-five suppliers are listed for this compound. Additional details are available on the furosemide profile page.
US ANDA Litigation and Generic Entry Outlook for Furosemide
A generic version of FUROSEMIDE was approved as furosemide by SANDOZ on August 14th, 1984.
Summary for FUROSEMIDE
| US Patents: | 0 |
| Applicants: | 34 |
| NDAs: | 58 |
| Suppliers / Packagers: | 44 |
| Bulk Api Vendors: | 115 |
| Clinical Trials: | 199 |
| Patent Applications: | 4,085 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for FUROSEMIDE |
| Drug Sales Revenues: | Drug sales revenues for FUROSEMIDE |
| DailyMed Link: | FUROSEMIDE at DailyMed |
See drug prices for FUROSEMIDE
Recent Clinical Trials for FUROSEMIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Otsuka Pharmaceutical Vietnam | N/A |
| Gia Dinh People Hospital | N/A |
| Assiut University | Phase 4 |
Pharmacology for FUROSEMIDE
| Drug Class | Loop Diuretic |
| Physiological Effect | Increased Diuresis at Loop of Henle |
Medical Subject Heading (MeSH) Categories for FUROSEMIDE
US Patents and Regulatory Information for FUROSEMIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Warner Chilcott | FUROSEMIDE | furosemide | TABLET;ORAL | 018419-002 | Jan 31, 1983 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Hikma | FUROSEMIDE | furosemide | TABLET;ORAL | 018823-002 | Nov 10, 1983 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Ani Pharms Inc | FUROSEMIDE | furosemide | TABLET;ORAL | 071379-001 | Jan 2, 1987 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
